Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

progress in medical research

In June 2024, a groundbreaking Alzheimer's research paper was retracted over fraud allegations. Did this mean billions of dollars and countless hours of research were wasted? Maybe not. Today, two promising drugs targeting amyloid beta, the focus of the paper, are available. This video explains the amyloid-beta hypothesis, the fraud, and what’s next.

Retracted Alzheimer’s Paper Reshapes Research Landscape, but Progress Continues

Substack subscription form sign up

Comments

  • Marco Messina on More Than a Third of Americans Have Lost Relationships Over Politics
  • Anon on Why Fructose Behaves Less Like a Calorie and More Like a Hormone
  • Mark Mellinger on Living Plastic Can Self-Destruct on Command
  • Marie Feret on The Silent Frequency That Makes Old Buildings Feel Haunted
  • Dax on The Silent Frequency That Makes Old Buildings Feel Haunted
© 2026 ScienceBlog.com | Follow our RSS / XML feed